Plant-made pharmaceuticals;OGM et production de molécules pharmaceutiques

Annales Pharmaceutiques Francaises

Volumn 61, Issue 2, 2003, Pages 109-118

  Faye, L ^a   Lerouge, P ^b   Gomord, V ^b  

^a UNIVERSITÉ DE ROUEN   (France)

^b NONE

Author keywords

Antibodies; Biotechnology; Genetically modified Plants; Glycosylation; Recombinant Proteins

Indexed keywords

ABCIXIMAB; ALEMTUZUMAB; ANTIBODY; BASILIXIMAB; DACLIZUMAB; GEMTUZUMAB OZOGAMICIN; INFLIXIMAB; MONOCLONAL ANTIBODY; OKT 3; ORTHOCLONE; PALIVIZUMAB; RITUXIMAB; TRASTUZUMAB;

ANTIBODY PRODUCTION; DRUG MANUFACTURE; DRUG MARKETING; DRUG SYNTHESIS; HUMAN; PLANT BIOTECHNOLOGY; PROTEIN GLYCOSYLATION; REVIEW; RISK ASSESSMENT; TRANSGENIC PLANT;

ANIMALS; ANTIBODIES, MONOCLONAL; GLYCOSYLATION; HUMANS; PLANTS; PLANTS, GENETICALLY MODIFIED; RECOMBINANT PROTEINS;

EID: 0345269243     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Sijmons PC, Dekker BM, Schrammeijer B, Verwoerd TC, van den Elzen PJ, Hoekema A. Production of correctly processed serum albumin in transgenic plants. Bio/Technology 1990; 8: 217-21.
2. Goddjin OJM, Pen J. Plants as bioreactors. Trends Biotechnol 1995; 13: 379-87.
3. Zhong GY, Peterson DJ, Delaney D, Bailey M, Witcher DR, Register JC et al. Commercial production of aprotinin in transgenic maize seeds. Mol Breeding 1999; 5: 345-56.
4. Vandekerckhove J et al. Enkephalines produced in transgenic plants using modified 2S storage proteins. Bio/Technology 1989; 7: 929-32.
5. Dieryck W, Pagnier J, Poyart G, Marden MC, Gruber V, Bournat P et al. Human haemoglobin from transgenic tobacco, Nature 1997; 386: 29-30.
6. Halling-Sorensen B, Nors Nielsen S, Lanzky PF, Ingerslev F, Holten Lutzhoft HC, Jorgensen SE. Occurrence, fate and effects of pharmaceutical substances in the environment. Chemosphere 1998; 36: 357-93.
7. Dieryck W, Gruber V, Baudino S, Lenee P, Pagnier J, Merot B et al. Expression of recombinant human hemoglobin in plants. Transfus Clin Biol 1995; 2: 441-7.
8. Richter LJ, Thanavala Y, Arntzen CJ, Mason HS. Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat Biotechnol 2000; 18: 1167-71.
9. James EA, Wang C, Wang Z. Production and characterization of biologically active human GM-CSF secreted by genetically modified plant cells. Protein Expr Purif 2000; 19: 131-8.
10. Matsumoto S, Ikura K, Ueda M, Sasaki R. Characterization of a human glycoprotein (erythropoietin) produced in cultured tobacco cells. Plant Mol Biol 1995; 27: 1163-72.
11. Hamamoto H, Sugiyama Y, Nakagawa N, Hashida E, Matsunaga Y, Takemoto S et al. A new tobacco mosaic virus vector and its use for the systematic production of angiotensin-I-converting enzyme inhibitor in transgenic tobacco and tomatoe. Bio/Technology 1993; 11: 930-2.
12. Cramer CL, Weissenborn DL, Oishi KK, Grabau EA, Bennett S, Ponce E et al. Bioproduction of human enzymes in transgenic tobacco. Ann NY Acad 1996; 79: 62-71.
13. Steiner UP. Assessment of the economics of transgenic technologies for biologicals, Bayer Biotechnology, Bayer Corp., communication dans le cadre du congrès Production and economics of biopharmaceuticals. CA, 13-15 janvier 2000.
14. Hudson PJ. Recombinant antibody fragments. Current opinion in biotechnology 1998; 9: 395-402.
15. Hiatt AC, Cafferkey R, Bowdish K. Production of antibodies in transgenic plants. Nature 1989; 342: 76-8.
16. Khoudi H, Laberge S, Ferullo JM, Bazin R, Darveau A, Castonguay Y, et al. Production of a diagnostic monoclonal antibody in perennial alfalfa plants. Biotech Bioeng 1999; 64: 135-43.
17. Smith MD, Glick BR. The production of antibodies in plants. Biotechnol Adv 2000; 18: 85-9.
18. Conrad U, Fiedler U, Artsaenko O, Phillips J. High-level and stable accumulation of single-chain Fv antibodies in plant storage organs. J Plant Physiol 1998; 152: 708-11.
19. Verch T, Yusibov V, Joprowski H. Expression and assembly of a full-lenght monoclonal antibody in plants using a plant virus vector. J Immunol 1998; 220: 69-74.
20. Stoger E, Vaquero C, Torres E, Sack M, Nicholson L, Drossard J, et al. Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies. Plant Mol Biol 2000; 42: 583-90.
21. Austin S, Bingham ET, Koegel RG, Mathews DE, Shahan MN, Straub RJ, et al. An overview of feasability study for the production of industrial enzymes in transgenic alfaf. Annu NY Acad Sci 1994; 721: 235-44.
22. Khoudi H, Laberge S, Ferullo JM, Bazin R, Darveau A, Castonguay Y, et al. Production of a diagnostic monoclonal antibody in perennial alfalfa plants. Biotech Bioeng 1999; 64: 135-43.
23. Houdebine LM. From animal transgenesis to molecular farming, in Molecular Farming Proceeding of the OECD workshop held in «la Grande Motte», septembre 2000.
24. Parmenter DL, Boothe JG, van Rooijen GJ, Yeung EC, Moloney MM. Production of biologically active hirudin in plant seeds using oleosin partitioning. Plant Mol Biol 1995; 29: 1167-80.
25. Boothe JG, Saponja JA, Parmenter DL. Molecular farming in plants: oilseed as vehicles for the production of pharmaceutical proteins. Drug Develop Res 1997; 42: 172-218.
26. Cabanes-Macheteau M, Fitchette-Laine AC, Loutelier-Bourhis C, Lange C, Vine ND, Ma JK et al. N-Glycosylation of a mouse IgG expressed in transgenic tobacco plants. Glycobiology 1999; 9: 365-72.
27. Fitchette-Lainé AC, Gomord V, Chekkafi A, Faye L. Distribution of xylosylation and fucosylation in the plant Golgi apparatus. Plant J 1994; 5: 673-82.
28. Garcia-Casado G, Sanchez-Monge R, Chrispeels MJ, Armentia A, Salcedo G, Gomez L. Role of complex asparagine-linked glycans in the allergenicity of plant glycoproteins. Glycobiology 1996; 6: 471-7.
29. van Ree R, Cabanes-Macheteau M, Akkerdaas J, Milazzo JP, Loutelier-Bourhis C, Rayon C et al. β(1,2)-xylose and α(1,3)-fucose residues have a strong contribution in IgE binding to plant glycoallergens. J Biol Chem 2000; 275: 11451-8.
30. Lerouge P, Cabanes-Macheteau M, Rayon C, Fitchette- Lainé AC, Gomord V, Faye L. N-glycoprotein biosynthesis in plants: recent developments and future trends. Plant Mol Biol 1998; 38: 31-48.
31. von Schaewen A, Sturm A, O'Neill J, Chrispeels MJ. Isolation of a mutant Arabidopsis plant that lacks N-acetyl glucosaminyl transferase I and is unable to synthesize Golgi-modified complex N-linked glycans. Plant Physiol 1993; 102: 1109-18.
32. Strasser R, Mucha J, Schwihla H, Altmann F, Glössl J, Steinkellner H. Molecular cloning and characterization of cDNA coding for β1,2N-acetylglusaminyltransferase I from Nicotiana tabacum. Glycobiology 1999; 9: 779-85.
33. Wenderoth I, von Schaeven A. Isolation and characterization of plant N-acetylglucosaminyltransferase I (GNT I) cDNA sequences. Functional analyses in the arabidopsis cgl mutant and in antisens plants. Plant Physiol 2000; 123: 1097-108.
34. Bakker H, Bardor M, Molthoff JW, Gomord V, Elbers I, Stevens LH et al. Galactose-extended glycans of antibodies produced by transgenic plants. Proc Natl Acad Sci, USA 2001; 98: 2899-904.